dc.contributor.author | Hounkpatin, Aurore B. | |
dc.contributor.author | Kreidenweiss, Andrea | |
dc.contributor.author | Held, Jana | |
dc.date.accessioned | 2020-06-22T06:28:08Z | |
dc.date.available | 2020-06-22T06:28:08Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 1178-6973 | |
dc.identifier.uri | http://hdl.handle.net/10900/101689 | |
dc.language.iso | en | de_DE |
dc.publisher | Dove Medical Press Ltd | de_DE |
dc.relation.uri | http://dx.doi.org/10.2147/IDR.S151031 | de_DE |
dc.subject.ddc | 610 | de_DE |
dc.title | Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria : a review on the mode of action and emerging trial data | de_DE |
dc.type | Article | de_DE |
utue.quellen.id | 20190926111821_03171 | |
utue.publikation.seiten | 553-570 | de_DE |
utue.personen.roh | Hounkpatin, Aurore B. | |
utue.personen.roh | Kreidenweiss, Andrea | |
utue.personen.roh | Held, Jana | |
dcterms.isPartOf.ZSTitelID | Infection and Drug Resistance | de_DE |
dcterms.isPartOf.ZS-Volume | 12 | de_DE |
utue.fakultaet | 04 Medizinische Fakultät | de_DE |
Dateien | Größe | Format | Anzeige |
---|---|---|---|
Zu diesem Dokument gibt es keine Dateien. |